Two Phase 3 controlled trials with substantially similar design to enroll 1,200 subjects with diabetic CKDWINSTON-SALEM, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (“ProKidney”), a ...